Dario G. Gomez

Person

Irvine, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,849,113
- Issue date Dec 26, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,623,006
- Issue date Apr 18, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coumarin compounds as receptor modulators with therapeutic utility
- Patent number 9,572,792
- Issue date Feb 21, 2017
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coumarin compounds as receptor modulators with therapeutic utility
- Patent number 9,073,888
- Issue date Jul 7, 2015
- Allergan, Inc.
- Todd M. Heidelbaugh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating alpha adrenergic mediated conditions
- Patent number 9,034,910
- Issue date May 19, 2015
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective alpha 2B/2C agonists
- Patent number 8,329,918
- Issue date Dec 11, 2012
- Allergan Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Patent number 8,071,635
- Issue date Dec 6, 2011
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating alpha adrenergic mediated conditions
- Patent number 8,071,636
- Issue date Dec 6, 2011
- Allergan, Inc.
- Wenkui K. Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Patent number 8,063,087
- Issue date Nov 22, 2011
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating alpha adrenergic mediated conditions
- Patent number 8,063,231
- Issue date Nov 22, 2011
- Allergan, Inc.
- Wenkui K. Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 2-aminotetralin derivatives as selective alpha 2B agonist
- Patent number 7,829,587
- Issue date Nov 9, 2010
- Allergan, Inc.
- John R. Cappiello
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Patent number 7,419,994
- Issue date Sep 2, 2008
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Patent number 7,345,077
- Issue date Mar 18, 2008
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Patent number 7,091,232
- Issue date Aug 15, 2006
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidiazoles having reduced side effects
- Patent number 6,841,684
- Issue date Jan 11, 2005
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20230062049
- Publication date Mar 2, 2023
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20200330428
- Publication date Oct 22, 2020
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180344692
- Publication date Dec 6, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180071260
- Publication date Mar 15, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20170172982
- Publication date Jun 22, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20150265573
- Publication date Sep 24, 2015
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20150224080
- Publication date Aug 13, 2015
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
- Publication number 20120328661
- Publication date Dec 27, 2012
- Allergan, Inc.
- Todd M. Heidelbaugh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20120165380
- Publication date Jun 28, 2012
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20120035235
- Publication date Feb 9, 2012
- Allergan, Inc.
- Wenkui K. Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC COMPOUNDS
- Publication number 20110178143
- Publication date Jul 21, 2011
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective Alpha 2B/2C Agonists
- Publication number 20110028523
- Publication date Feb 3, 2011
- Allergan, Inc.
- Phong X. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20090306398
- Publication date Dec 10, 2009
- Allergan, Inc.
- Wenkui K. Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20090306161
- Publication date Dec 10, 2009
- Allergan, Inc.
- Wenkui K. Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 2-AMINOTETRALIN DERIVATIVES AS SELECTIVE ALPHA 2B AGONIST
- Publication number 20090176845
- Publication date Jul 9, 2009
- John R. Cappietto
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(SUBSTITUTED CYCLOALKYLMETHYL) IMIDAZOLE-2-THIONES, 4-(SUBSTITUTE...
- Publication number 20080319013
- Publication date Dec 25, 2008
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substitute...
- Publication number 20080221186
- Publication date Sep 11, 2008
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Publication number 20060149072
- Publication date Jul 6, 2006
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(Substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Publication number 20050267186
- Publication date Dec 1, 2005
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...
- Publication number 20040220402
- Publication date Nov 4, 2004
- Ken Chow
- C07 - ORGANIC CHEMISTRY

Dario G. Gomez

Person

Patents Grantslast 30 patents

Methods of treating α adrenergic mediated conditions

Methods of treating α adrenergic mediated conditions

Coumarin compounds as receptor modulators with therapeutic utility

Coumarin compounds as receptor modulators with therapeutic utility

Methods of treating alpha adrenergic mediated conditions

Selective alpha 2B/2C agonists

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

Methods of treating alpha adrenergic mediated conditions

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

Methods of treating alpha adrenergic mediated conditions

Substituted 2-aminotetralin derivatives as selective alpha 2B agonist

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

Imidiazoles having reduced side effects

Patents Applicationslast 30 patents

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

COUMARIN COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

THERAPEUTIC COMPOUNDS

Selective Alpha 2B/2C Agonists

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

SUBSTITUTED 2-AMINOTETRALIN DERIVATIVES AS SELECTIVE ALPHA 2B AGONIST

4-(SUBSTITUTED CYCLOALKYLMETHYL) IMIDAZOLE-2-THIONES, 4-(SUBSTITUTE...

4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substitute...

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

4-(Substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...

4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substitute...